Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
โ
of holders' portfolios
13F filers
0
institutions
52-week range
$0.06 โ $0.31
8% from low
Exchange
OTC Link
OS
IMUGENE LTD
No one on the platform currently holds IUGNF.
No tracked institution reports a position in IUGNF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2025-07-02 | 1-for-34reverse |
| 2015-10-28 | 17-for-15 |
No one on the platform has traded IUGNF yet.
No recent Form 4 filings on EDGAR โ either no insider transactions reported recently or this isn't a SEC-registered issuer.
$IUGNF at some point this company has to show something for alll the millions of stock holders . Or just call it quits .
View on StockTwits โ$IUGNF I used AI to create this meme that pretty much explains Paul, Leslie, and the whole company.
View on StockTwits โ$IUGNF share purchase plan only for those in Australia & New Zealand!! A little unfair. ๐๐ผ
View on StockTwits โ$IUGNF wheres this going. I really think company is running out of money. They talk a good game. But have nothing to show at this point.
View on StockTwits โ$IUGNF this will keep splitting and investors will keep losing . I hate this
View on StockTwits โ$IUGNF rvs price. .34 or so am i correct or wrong
View on StockTwits โ$IUGNF lets move this sp. Company is taking action to help.
View on StockTwits โ$IUGNF as company said in there shareholder letter. They cant control stock price. But understand that investors are worried. Maybe bringing shares down will help . I dont know. i would end upp with 588 shares if split today. Would be better to wait with good news on the horizon.
View on StockTwits โ$IUGNF whatever it takes move to nasdaq knowing that excellent phase results are in the mix. Screw this 1 for 34 split.
View on StockTwits โRecent $TICKER stream from stocktwits.com โ refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $2M | +1.8% | $-0.08 | $-0.08โ$-0.08 | โ | 1 |
| 2028 | $17M | +908.0% | $-0.04 | $-0.04โ$-0.04 | โ | 1 |
| 2029 | $984M | +5661.7% | $1.73 | $1.73โ$1.73 | 0.0ร | 1 |
Forward consensus ยท growth is YoY vs the prior fiscal-year estimate ยท Fwd P/E at the current price ยท source: Financial Modeling Prep
Beat consensus in 3 of the last 4 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-02-25 | $-0.23 | $-0.09 | +61.8% |
| 2025-08-04 | $-0.22 | $-0.06 | +72.4% |
| 2025-02-26 | $-0.21 | $-0.14 | +34.7% |
| 2024-08-30 | $-0.23 | $-0.25 | -11.3% |
| $112M |
| โ |
| MSCLFSatellos Bioscience Inc. | $6.25 | +11.81% | $97M | โ |
| NICXFNicox S.A. | $0.30 | +0.00% | $29M | โ |
Source: Financial Modeling Prep ยท peers by sector/industry